DJIA 16,123.76 -251.00 -1.53%
NASDAQ 4,688.18 -45.32 -0.96%
S&P 500 1,921.23 -29.90 -1.53%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

80.33 -1.27 (-1.56%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LLY $80.33 -1.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $80.64
Previous Close $81.60
Daily Range $79.68 - $81.11
52-Week Range $60.58 - $90.18
Market Cap $89.0B
P/E Ratio 42.28
Dividend (Yield) $2.00 (2.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,880,237
Average Daily Volume 4,308,833
Current FY EPS $3.27




Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website:

News & Commentary Rss Feed

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

3 Stocks Improving Performance Of The Drugs Industry

Amgen, Novartis Team Up; Bone Drug Positive in Phase III

Eli Lilly Is A Boring Stock... I Like Boring!

VHT, MRK, BMY, LLY: Large Outflows Detected at ETF

ESC- Case Builds For Jardiance

Bristol-Myers Inks Another Immuno-Oncology Drug Deal

Why Eli Lilly (LLY) Could Beat Earnings Estimates Again

Approval Of Repatha May Give Amgen A $5B Boost.

Eli Lilly's (LLY) Diabetes Drug Synjardy Gets U.S. Approval

See More LLY News...

LLY's Top Competitors

LLY $80.33 (-1.56%)
Current stock: LLY
JNJ $91.36 (-1.38%)
Current stock: JNJ
NVS $94.68 (-0.71%)
Current stock: NVS
RHHBY $33.36 (-0.13%)
Current stock: RHHBY